Additionally, the presence of the BCR::ABL1 fusion supports the classification of this leukemia as MPAL (T/myeloid) with a defined genetic abnormality, in accordance with the World Health Organization (WHO), fifth edition, and the International Consensus Classification (ICC) [1,8]. This evidence concerns the gene ABL1 and leukemia.